Peptide-Polyanion Conjugate to Activate STING Innate Immune Signaling
Invention type: Technology
/
Case number: #26286
Researchers
Justin Kaskow
/
Paula Hammond
Departments: Chemical Engineering, Office of the Provost
Technology Areas: Biotechnology: Synthetic Biology / Therapeutics: Cell Based Therapy, Proteins & Antibodies
Impact Areas: Healthy Living
-
peptide-polyanion conjugate to activate sting innate immune signaling
United States of America | Pending
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.